7. REFERENCES
Akkari, A. C. S., Papini, J. Z. B., Garcia, G. K., Franco, M. K. K. D., Cavalcanti, L. P., Gasperini, A., De Araujo, D. R. (2016). Poloxamer 407/188 binary thermosensitive hydrogels as delivery systems for infiltrative local anesthesia: Physico-chemical characterization and pharmacological evaluation. Materials Science and Engineering C ,68 , 299–307. https://doi.org/10.1016/j.msec.2016.05.088
Arama, D. P., Soualmia, F., Lisowski, V., Longevial, J. F., Bosc, E., Maillard, L. T., … El Amri, C. (2015). Pyrido-imidazodiazepinones as a new class of reversible inhibitors of human kallikrein 7.European Journal of Medicinal Chemistry , 93 , 202–213. https://doi.org/10.1016/j.ejmech.2015.02.008
Avgeris, M., Mavridis, K., & Scorilas, A. (2012). Kallikrein-related peptidases in prostate, breast, and ovarian cancers: From pathobiology to clinical relevance. Biological Chemistry , 393 (5), 301–317. https://doi.org/10.1515/hsz-2011-0260
Ban, E., Park, M., Jeong, S., Kwon, T., Kim, E. H., Jung, K., & Kim, A. (2017). Poloxamer-based thermoreversible gel for topical delivery of emodin: Influence of P407 and P188 on solubility of emodin and its application in cellular activity screening. Molecules ,22 (2). https://doi.org/10.3390/molecules22020246
Batrakova, E. V., & Kabanov, A. V. (2008). Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiers. Journal of Controlled Release , 130 (2), 98–106. https://doi.org/10.1016/j.jconrel.2008.04.013
Beer, L. A., Tatge, H., Schneider, C., Ruschig, M., Hust, M., Barton, J., … Gerhard, R. (2018). The binary toxin CDT of Clostridium difficile as a tool for intracellular delivery of bacterial glucosyltransferase domains. Toxins , 10 (6). https://doi.org/10.3390/toxins10060225
Blaber, S. I., Bogoljub, C., Christophi, G. P., Bernett, M. J., Blaber, M., Rodriguez, M., & Scarisbrick, I. A. (2005). Targeting kallikrein 6-proteolysis attenuates CNS inflammatory disease, 5 (January), 920–922.
Borgoño, C. a, Michael, I. P., & Diamandis, E. P. (2004). Human tissue kallikreins: physiologic roles and applications in cancer.Molecular Cancer Research : MCR , 2 (5), 257–280. https://doi.org/2/5/257 [pii]
Bradbury, A. R. M., Sidhu, S., Dübel, S., & Mccafferty, J. (2011). Beyond natural antibodies: the power of in vitro display technologies.Nature Biotechnology , 29 (3), 245–254. https://doi.org/10.1038/nbt.1791.Beyond
Breitling, F., Dübel, S., Seehaus, T., Klewinghaus, I., & Little, M. (1991). A surface expression vector for antibody screening. Gene ,104 (2), 147–153. https://doi.org/10.1016/0378-1119(91)90244-6
Cera, E. Di, & Di Cera, E. (2009). Serine Proteases. IUBMB Life ,61 (5), 510–515. https://doi.org/10.1002/iub.186.Serine
Chavanas, S., Bodemer, C., Rochat, A., Hamel-Teillac, D., Ali, M., Irvine, A. D., … Hovnanian, A. (2000). Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome.Nature Genetics , 25 (2), 141–142. https://doi.org/10.1038/75977
De Souza, L. R., M. Melo, P., Paschoalin, T., Carmona, A. K., Kondo, M., Hirata, I. Y., … Puzer, L. (2013). Human tissue kallikreins 3 and 5 can act as plasminogen activator releasing active plasmin.Biochemical and Biophysical Research Communications ,433 (3), 333–337. https://doi.org/10.1016/j.bbrc.2013.03.001
Descargues, P., Draison, C., Bonnart, C., Kreft, M., Kishibe, M., Ishida-Yamamoto, A., … Hovnanian, A. (2005). Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity. Nature Genetics , 37 (1), 56–65. https://doi.org/10.1038/ng1493
Diamandis, E. P., Yousef, G. M., Luo, L. Y., Magklara, A., & Obiezu, C. V. (2000). The new human kallikrein gene family: Implications in carcinogenesis. Trends in Endocrinology and Metabolism ,11 (2), 54–60. https://doi.org/10.1016/S1043-2760(99)00225-8
Dorraj, G., & Moghimi, H. R. (2015). Preparation of SLN-containing thermoresponsive in-situ forming gel as a controlled nanoparticle delivery system and investigating its rheological, thermal and erosion behavior. Iranian Journal of Pharmaceutical Research ,14 (2), 347–358.
dos Santos, A. C. M., Akkari, A. C. S., Ferreira, I. R. S., Maruyama, C. R., Pascoli, M., Guilherme, V. A., de Araujo, D. R. (2015). Poloxamer-based binary hydrogels for delivering tramadol hydrochloride: Sol-gel transition studies, dissolution-release kinetics, in vitro toxicity, and pharmacological evaluation. International Journal of Nanomedicine , 10 , 2391–2401. https://doi.org/10.2147/IJN.S72337
Dumortier, G., Grossiord, J. L., Agnely, F., & Chaumeil, J. C. (2006). A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharmaceutical Research , 23 (12), 2709–2728. https://doi.org/10.1007/s11095-006-9104-4
Ekholm, E., & Egelrud, T. (1999). Stratum corneum chymotryptic enzyme in psoriasis. Archives of Dermatological Research , 291 (4), 195–200. https://doi.org/10.1007/s004030050393
Freitas Mariano, K. C., Monteiro do Nascimento, M. H., Querobino, S. M., Ramos Campos, E. V., de Oliveira, J. L., Yokaichiya, F., de Araujo, D. R. (2019). Influence of chitosan-tripolyphosphate nanoparticles on thermosensitive polymeric hydrogels: structural organization, drug release mechanisms and cytotoxicity. International Journal of Polymeric Materials and Polymeric Biomaterials , 0 (0), 1–12. https://doi.org/10.1080/00914037.2019.1596909
Freitas, R. F., Teixeira, T. S. P., Barros, T. G., Santos, J. A. N., Kondo, M. Y., Juliano, M. A., … Puzer, L. (2012). Isomannide derivatives as new class of inhibitors for human kallikrein 7.Bioorganic and Medicinal Chemistry Letters , 22 (19), 6072–6075. https://doi.org/10.1016/j.bmcl.2012.08.047
Frenzel, A., Schirrmann, T., & Hust, M. (2016). Phage display derived human antibodies in clinical development and therapy. MAbs ,0862 (August), In Press. https://doi.org/10.1080/19420862.2016.1212149
Smith, G.P. (1985). Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science ,228 (4705), 1315–1317.
He, Z., Zhan, X., Zheng, Q., Zhu, L., Wang, Xi., Deng, L., & Bin, L. (2017). Enhanced expression ok kallikrein-relatd peptidase 7 in Lichen planus, Lichen sclerosis, porokeratosis and Psoriasis vulgaris.Journal of Dermatological Research , 2 (1), 103–109. https://doi.org/10.17554/j.issn.2413-8223.2017.02.24
Hust, M., Jonas, K., & Tomszak, F. (2018). Construction of Human Immune and Naive scFv Libraries, 1701 . https://doi.org/10.1007/978-1-4939-7447-4
Hutt, M., Fellermeier-Kopf, S., Seifert, O., Schmitt, L. C., Pfizenmaier, K., & Kontermann, R. E. (2018). Targeting scFv-Fc-scTRAIL fusion proteins to tumor cells. Oncotarget , 9 (13), 11322–11335. https://doi.org/10.18632/oncotarget.24379
Igawa, S., Kishibe, M., Minami-Hori, M., Honma, M., Tsujimura, H., Ishikawa, J., … Ishida-Yamamoto, A. (2017). Incomplete KLK7 Secretion and Upregulated LEKTI Expression Underlie Hyperkeratotic Stratum Corneum in Atopic Dermatitis. Journal of Investigative Dermatology , 137 (2), 449–456. https://doi.org/10.1016/j.jid.2016.10.015
Ishida-Yamamoto, A., & Igawa, S. (2015). The biology and regulation of corneodesmosomes. Cell and Tissue Research , 360 (3), 477–482. https://doi.org/10.1007/s00441-014-2037-z
Ishida-Yamamoto, A., Simon, M., Kishibe, M., Miyauchi, Y., Takahashi, H., Yoshida, S., … Iizuka, H. (2004). Epidermal lamellar granules transport different cargoes as distinct aggregates. Journal of Investigative Dermatology , 122 (5), 1137–1144. https://doi.org/10.1111/j.0022-202X.2004.22515.x
Jäger, V., Büssow, K., Wagner, A., Weber, S., Hust, M., Frenzel, A., & Schirrmann, T. (2013). High level transient production of recombinant antibodies and antibody fusion proteins in HEK293 cells.
Jendrny, C., & Beck-Sickinger, A. G. (2016). Inhibition of Kallikrein-Related Peptidases 7 and 5 by Grafting Serpin Reactive-Center Loop Sequences onto Sunflower Trypsin Inhibitor-1 (SFTI-1).ChemBioChem , 17 (8), 719–726. https://doi.org/10.1002/cbic.201500539
Jonca, N., Leclerc, E. A., Caubet, C., Simon, M., Guerrin, M., & Serre, G. (2011). Corneodesmosomes and corneodesmosin: From the stratum corneum cohesion to the pathophysiology of genodermatoses. European Journal of Dermatology , 21 (2 SUPPL), 35–42. https://doi.org/10.1684/ejd.2011.1264
Klement, M., Zheng, J., Liu, C., Tan, H., Vai, V., Wong, T., Ow, D. S. (2017). Antibody engineering of a cytotoxic monoclonal antibody 84 against human embryonic stem cells : Investigating the effects of multivalency on cytotoxicity. Journal of Biotechnology ,243 , 29–37. https://doi.org/10.1016/j.jbiotec.2016.12.019
Koffi, A. A., Agnely, F., Ponchel, G., & Grossiord, J. L. (2006). Modulation of the rheological and mucoadhesive properties of thermosensitive poloxamer-based hydrogels intended for the rectal administration of quinine. European Journal of Pharmaceutical Sciences , 27 (4), 328–335. https://doi.org/10.1016/j.ejps.2005.11.001
Komatsu, N., Saijoh, K., Jayakumar, A., Clayman, G. L., Tohyama, M., Suga, Y., Diamandis, E. P. (2008). Correlation between SPINK5 gene mutations and clinical manifestations in Netherton syndrome patients.Journal of Investigative Dermatology , 128 (5), 1148–1159. https://doi.org/10.1038/sj.jid.5701153
Komatsu, N., Saijoh, K., Otsuki, N., Kishi, T., Micheal, I. P., Obiezu, C. V., Diamandis, E. P. (2007). Proteolytic processing of human growth hormone by multiple tissue kallikreins and regulation by the serine protease inhibitor Kazal-Type5 (SPINK5) protein. Clinica Chimica Acta , 377 (1–2), 228–236. https://doi.org/10.1016/j.cca.2006.10.009
Komatsu, N., Suga, Y., Saijoh, K., Liu, A. C., Khan, S., Mizuno, Y., Diamandis, E. P. (2006). Elevated human tissue kallikrein levels in the stratum corneum and serum of peeling skin syndrome-type B patients suggests an over-desquamation of corneocytes [3]. Journal of Investigative Dermatology , 126 (10), 2338–2342. https://doi.org/10.1038/sj.jid.5700379
Kryza, T., Silva, M. L., Loessner, D., Heuzé-Vourc’h, N., & Clements, J. A. (2016). The kallikrein-related peptidase family: Dysregulation and functions during cancer progression. Biochimie , 122 , 283–299. https://doi.org/10.1016/j.biochi.2015.09.002
Kügler, J., Wilke, S., Meier, D., Tomszak, F., Frenzel, A., Schirrmann, T., Hust, M. (2015). Generation and analysis of the improved human HAL9/10 antibody phage display libraries. BMC Biotechnology ,15 , 10. https://doi.org/10.1186/s12896-015-0125-0
Lombello, C. B., Malmonge, S. M., & Wada, M. L. F. (2000). PolyHEMA and polyHEMA-poly ( MMA-co-AA ) as substrates for culturing Vero cells.Journal of Materials Science: Materials in Medicine , 1 , 541–546.
Lundwall, Å., & Brattsand, M. (2008). Kallikrein-related peptidases.Cellular and Molecular Life Sciences , 65 (13), 2019–2038. https://doi.org/10.1007/s00018-008-8024-3
Marty, C., & Schwendener, R. A. (2005). Cytotoxic tumor targeting with scFv antibody-modified liposomes. Methods in Molecular Medicine ,109 , 389–402. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15585933
McCafferty, J., Griffiths, A. D., Winter, G., & Chiswell, D. J. (1990). Phage antibodies: filamentous phage displaying antibody variable domains. Nature . https://doi.org/10.1038/348552a0
Mosmann, T. (1983). Rapid Colorimetric Assay for Cellular Growth and Survival : Application to Proliferation and Cytotoxicity Assays.Journal of Immunological Methods , 65 , 55–63.
Nascimento, M. H. M., Ferreira, M., Malmonge, S. M., & Lombello, C. B. (2017). Evaluation of cell interaction with polymeric biomaterials based on hyaluronic acid and chitosan. Journal of Materials Science: Materials in Medicine , 28 (68), 1–11. https://doi.org/10.1007/s10856-017-5875-x
Nascimento, M. H. M., Franco, M. K. K. D., Yokaichyia, F., de Paula, E., Lombello, C. B., & de Araujo, D. R. (2018). Hyaluronic acid in Pluronic F-127/F-108 hydrogels for postoperative pain in arthroplasties: Influence on physico-chemical properties and structural requirements for sustained drug-release. International Journal of Biological Macromolecules , 111 , 1245–1254. https://doi.org/10.1016/j.ijbiomac.2018.01.064
Oliveira, J. P. C., Freitas, R. F., Melo, L. S. De, Barros, T. G., Santos, J. A. N., Juliano, M. A., Puzer, L. (2014). Isomannide-based peptidomimetics as inhibitors for human tissue kallikreins 5 and 7.ACS Medicinal Chemistry Letters , 5 (2), 128–132. https://doi.org/10.1021/ml4003698
Paliouras, M., Borgono, C., & Diamandis, E. P. (2007). Human tissue kallikreins: The cancer biomarker family. Cancer Letters ,249 (1), 61–79. https://doi.org/10.1016/j.canlet.2006.12.018
Pampalakis, G., & Sotiropoulou, G. (2007). Tissue kallikrein proteolytic cascade pathways in normal physiology and cancer.Biochimica et Biophysica Acta - Reviews on Cancer ,1776 (1), 22–31. https://doi.org/10.1016/j.bbcan.2007.06.001
Patel, S. (2017). A critical review on serine protease: Key immune manipulator and pathology mediator. Allergologia et Immunopathologia , 45 (6), 579–591. https://doi.org/10.1016/j.aller.2016.10.011
Pillai, O., & Panchagnula, R. (2003). Transdermal delivery of insulin from poloxamer gel: Ex vivo and in vivo skin permeation studies in rat using iontophoresis and chemical enhancers. Journal of Controlled Release , 89 (1), 127–140. https://doi.org/10.1016/S0168-3659(03)00094-4
Prassas, I., Eissa, A., Poda, G., & Diamandis, E. P. (2015). Unleashing the therapeutic potential of human kallikrein-related serine proteases.Nature Reviews. Drug Discovery , 14 (3), 183–202. https://doi.org/10.1038/nrd4534
Russo, G., Meier, D., Helmsing, S., Wenzel, E., Hust, M., & Oberle, F. (2018). Parallelized Antibody Selection in Microtiter Plates,1701 , 273–284. https://doi.org/10.1007/978-1-4939-7447-4
Schirrmann, T., Meyer, T., Schütte, M., Frenzel, A., & Hust, M. (2011). Phage display for the generation of antibodies for proteome research, diagnostics and therapy. Molecules , 16 (1), 412–426. https://doi.org/10.3390/molecules16010412
Schmolka, I. R. (1972). Artificial Skin I . Preparation and Properties Treatment of Burns. Journal of Biomedical Materials Research ,6 , 571–582.
Sebaugh, J. L. (2011). Guidelines for accurate EC50/IC50 estimation.Pharmaceutical Statistics , 10 (2), 128–134. https://doi.org/10.1002/pst.426
Shaw, J. L. V, & Diamandis, E. P. (2007). Distribution of 15 human kallikreins in tissues and biological fluids. Clinical Chemistry ,53 (8), 1423–1432. https://doi.org/10.1373/clinchem.2007.088104
Shen, K., Shen, C., Chen, L., Chen, X., & Chen, Y. (2010). Morphological Alterations of Vero Cell Exposed to Coplanar PCB 126 and Noncoplanar PCB 153. Environmental Toxicology , 27 (1), 26–31. https://doi.org/10.1002/tox
Singh, R., Samant, U., Hyland, S., Chaudhari, P. R., Wels, W. S., & Bandyopadhyay, D. (2007). Target-specific cytotoxic activity of recombinant immunotoxin scFv(MUC1)-ETA on breast carcinoma cells and primary breast tumors. Molecular Cancer Therapeutics ,6 (2), 562–569. https://doi.org/10.1158/1535-7163.mct-06-0604
Sokolowska-Wedzina, A., Chudzian, J., Borek, A., Zakrzewska, M., Otlewski, J., & Chodaczek, G. (2017). High-affinity internalizing human scFv-Fc antibody for targeting FGFR1-overexpressing lung cancer.Molecular Cancer Research , 15 (8), 1040–1050. https://doi.org/10.1158/1541-7786.MCR-16-0136
Su, Y. L., Wang, J., & Liu, H. Z. (2002). FTIR spectroscopic study on effects of temperature and polymer composition on the structural properties of PEO-PPO-PEO block copolymer micelles. Langmuir ,18 (14), 5370–5374. https://doi.org/10.1021/la020007p
Teixeira, T. S. P., Freitas, R. F., Abrah??o, O., Devienne, K. F., De Souza, L. R., Blaber, S. I., … Puzer, L. (2011). Biological evaluation and docking studies of natural isocoumarins as inhibitors for human kallikrein 5 and 7. Bioorganic and Medicinal Chemistry Letters , 21 (20), 6112–6115. https://doi.org/10.1016/j.bmcl.2011.08.044
Tibbitt, M. W., Dahlman, J. E., & Langer, R. (2016). Emerging Frontiers in Drug Delivery. Journal of the American Chemical Society ,138 (3), 704–717. https://doi.org/10.1021/jacs.5b09974
Turk, B. (2006). Targeting proteases: successes, failures and future prospects. Nature Reviews. Drug Discovery , 5 (9), 785–799. https://doi.org/10.1038/nrd2092
Voegeli, R., Doppler, S., Joller, P., Breternitz, M., Fluhr, J. W., & Rawlings, A. V. (2011). Increased mass levels of certain serine proteases in the stratum corneum in acute eczematous atopic skin.International Journal of Cosmetic Science , 33 (6), 560–565. https://doi.org/10.1111/j.1468-2494.2011.00671.x
Wang, Y., Chen, W., Li, X., Cheng, B., Zinkernagel, R. M., Danilova, N., … Puzer, L. (2009). Therapeutic Antibodies . (A. S. Dimitrov, Ed.), Journal of Investigative Dermatology (Vol. 525). Totowa, NJ: Humana Press. https://doi.org/10.1007/978-1-59745-554-1
Zhang, Y., Lam, Y. M., & Tan, W. S. (2005). Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide)-g-poly(vinylpyrrolidone): Association behavior in aqueous solution and interaction with anionic surfactants. Journal of Colloid and Interface Science , 285 (1), 74–79. https://doi.org/10.1016/j.jcis.2004.12.033